Literature DB >> 7254838

Congenital choanal atresia.

A J Maniglia, W J Goodwin.   

Abstract

Bilateral choanal atresia is a medical emergency. With good nursing care and close observation, surgery may be delayed until it is deemed safe and there is a good chance of success. Surgical treatment of unilateral atresia is better delayed to optimize the conditions for successful surgery. There are three surgical approaches for the correction of this anomaly: transnasal, transpalatal, and trans-septal. Each has advantages and disadvantages. The patient's age is an important consideration in the choice of the technique. Partial vomer removal minimizes the likelihood of restenosis. It is widely accepted that the transnasal microsurgical technique has improved the safety and success rate in infants and younger children. The transpalatal or trans-septal approach is preferred in older children and adults.

Entities:  

Mesh:

Year:  1981        PMID: 7254838

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  4 in total

1.  UNILATERAL CHOANAL ATRESIA: A Case Report.

Authors:  Sunil Chaudhry; L K Kochhar; J R Galagali; N Ajay Kumar
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Endoscopic endonasal emergency management of bilateral choanal atresia in new borns.

Authors:  B T Hathiram; D S Grewal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1999-12

3.  Prosthetic Rehabilitation of Bilateral External Nasal Valve Area after Nasal Reconstruction for a Congenitally Missing Nose: A Clinical Report.

Authors:  K Subash Chander; Jayasree Komala; Ramaswamy Reddy; Mohammed Umair; Koineni Rajender; K Venkatesh
Journal:  J Int Oral Health       Date:  2015

4.  Treacher Collins Syndrome with choanal atresia: a case report and review of disease features.

Authors:  Eduardo C Andrade; Vanier S Júnior; Ana L S Didoni; Priscila Z Freitas; Araken F Carneiro; Fabiana R Yoshimoto
Journal:  Braz J Otorhinolaryngol       Date:  2006-01-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.